OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Clinical trial NCT01945489 · COMPLETED
Trial details
- NCT number
- NCT01945489
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-28
- Primary completion
- 2016-05-24
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.